hsa-mir-3662: Hsa-mir-3662 is a circulating miRNA that has been identified in various types of cancers, including lung adenocarcinoma and hepatocellular carcinoma [PMC7012856] [PMC8781987] [PMC4757586]. It has been suggested as a potential biomarker for the diagnosis of lung adenocarcinoma [PMC8781987]. Hsa-mir-3662 has also been found to be overexpressed in patients with SI tumor, indicating its potential to distinguish this group of patients from others [PMC9776661]. In addition, hsa-mir-3662 has been shown to have a significant effect on prognosis in cancer patients [PMC9389359]. It is one of the miRNAs that are often packed in extracellular vesicles, specifically exosomes [PMC7012856]. Hsa-mir-3662 is also known to have binding sites on certain genes, such as RORA and CD14, suggesting its regulatory role in gene expression [PMC8029983] [PMC9526608]. Furthermore, hsa-mir-3662 has been found to be associated with other miRNAs such as hsa-miR-144 and hsa-miR-3646, which have a high number of target genes in coexpression networks [PMC9461120]. Overall, hsa-mir-3662 is an important circulating miRNA that shows potential as a diagnostic biomarker and prognostic indicator in various types of cancers.